Stryker Co. (NYSE:SYK) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lowered its position in shares of Stryker Co. (NYSE:SYK - Free Report) by 0.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 163,076 shares of the medical technology company's stock after selling 1,550 shares during the period. Public Employees Retirement System of Ohio's holdings in Stryker were worth $58,913,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of SYK. Dunhill Financial LLC increased its holdings in shares of Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Centennial Bank AR lifted its stake in Stryker by 106.7% during the second quarter. Centennial Bank AR now owns 93 shares of the medical technology company's stock worth $32,000 after purchasing an additional 48 shares during the last quarter. Darwin Wealth Management LLC purchased a new stake in Stryker during the third quarter worth approximately $36,000. Hara Capital LLC purchased a new stake in Stryker during the third quarter worth approximately $42,000. Finally, HBW Advisory Services LLC purchased a new stake in Stryker during the third quarter worth approximately $42,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent analyst reports. BTIG Research boosted their target price on Stryker from $383.00 to $394.00 and gave the stock a "buy" rating in a research note on Wednesday, October 30th. Citigroup boosted their target price on Stryker from $406.00 to $411.00 and gave the stock a "buy" rating in a research note on Thursday, October 31st. Morgan Stanley upgraded Stryker from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $370.00 to $445.00 in a research note on Monday, December 2nd. Robert W. Baird boosted their price objective on Stryker from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. Finally, Wolfe Research started coverage on Stryker in a research note on Tuesday, September 10th. They issued an "outperform" rating and a $405.00 price objective for the company. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $398.40.

Stryker Price Performance

SYK stock traded down $4.15 on Monday, reaching $380.87. 559,246 shares of the company's stock were exchanged, compared to its average volume of 1,260,183. The stock has a fifty day moving average of $371.10 and a 200-day moving average of $353.67. Stryker Co. has a twelve month low of $285.79 and a twelve month high of $398.20. The firm has a market cap of $145.20 billion, a PE ratio of 41.27, a P/E/G ratio of 2.90 and a beta of 0.94. The company has a quick ratio of 1.22, a current ratio of 1.91 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.10. The company had revenue of $5.49 billion for the quarter, compared to analyst estimates of $5.37 billion. Stryker had a return on equity of 23.07% and a net margin of 16.34%. Stryker's revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.46 earnings per share. As a group, equities analysts predict that Stryker Co. will post 12.06 EPS for the current fiscal year.

Insider Buying and Selling at Stryker

In related news, VP M Kathryn Fink sold 2,121 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $370.00, for a total transaction of $784,770.00. Following the transaction, the vice president now directly owns 10,042 shares in the company, valued at approximately $3,715,540. This represents a 17.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin Lobo sold 57,313 shares of the stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $368.70, for a total value of $21,131,303.10. Following the transaction, the chief executive officer now owns 100,027 shares in the company, valued at $36,879,954.90. This trade represents a 36.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 66,781 shares of company stock valued at $24,612,275. Insiders own 5.50% of the company's stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.